Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection

NCT02175758

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Los Angeles, California, United States
  • San Francisco, California, United States
  • Washington D.C., District of Columbia, United States
  • Gainesville, Florida, United States
View all 37 locations
View Trial Details
Completed

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

NCT03118843

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
  • Inland Empire Liver Foundation Rialto, California, United States
View all 27 locations
View Trial Details
Completed

Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)

NCT01846494

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Anaheim Clinical Trials Anaheim, California, United States
  • Scripps Clinic San Diego, California, United States
  • Tuan Nguyen, MD San Diego, California, United States
  • Quest Clinical Research San Francisco, California, United States
View all 13 locations
View Trial Details
Completed

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

NCT03074331

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Seth GS Medical College and KEM hospital Mumbai, Maharashtra, India
  • Government Medical College & Super Speciality Hospital Nagpur, Maharashtra, India
  • Institute of Liver and Biliary Sciences New Delhi, National Capital Territory of Delhi, India
  • All India Institute of Medical Sciences Delhi, New Delhi, India
View all 16 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607800

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 93 locations
View Trial Details
Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

NCT02639247

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +20 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 78 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607735

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Palo Alto, California, United States
  • Pasadena, California, United States
View all 86 locations
View Trial Details

Related conditions